Cas no 1134-49-2 (5-phenyl-1h-pyrazole-3-carboxylic acid)
5-phenyl-1h-pyrazole-3-carboxylic acid Chemical and Physical Properties
Names and Identifiers
-
- 3-Phenyl-1H-pyrazole-5-carboxylic acid
- 1H-Pyrazole-5-carboxylicacid, 3-phenyl-
- 5-PHENYL-1H-PYRAZOLE-3-CARBOXYLIC ACID
- 3-phenyl-1H-pyrazole-5-carboxylic acid(SALTDATA: FREE)
- 3-Phenylpyrazole-5-carboxylic acid
- 5-Phenyl-2H-pyrazole-3-carboxylic acid
- 1H-Pyrazole-3-carboxylic acid, 5-phenyl-
- Pyrazole-5-carboxylic acid, 3-phenyl-
- Pyrazole-3-carboxylic acid, 5-phenyl-
- QBPUOAJBMXXBNU-UHFFFAOYSA-N
- 1H-Pyrazole-3-carboxylicacid, 5-phenyl-
- SMR000124836
- 5-Phenyl-1H-pyrazole-3-carboxylicacid
- 3-Phenyl-1H-pyrazole-5-carboxylic acid, 97%
- P2021
- BRN 0609874
- FS-1871
- DTXSID60150398
- J-513035
- 5-phenyl-3-pyrazole carboxylic acid
- SR-01000597145-1
- SCHEMBL69492
- AKOS005485835
- 5-PHENYL-PYRAZOLE-3-CARBOXYLIC ACID
- KUC107418N
- MLS000067411
- EU-0099922
- FT-0678418
- KSC-20-088
- 1134-49-2
- MFCD05170017
- CHEBI:92735
- 5-Phenyl-1H-pyrazole-3-carboxylic acid #
- CS-W022423
- AKOS000271465
- BB 0219050
- AKOS000263428
- F0348-3292
- MLS003585704
- HMS2206M19
- CCG-202902
- AB08419
- FT-0713944
- 2-Bromo-2,6-difluoroacetophenone
- A871479
- 3-(phenyl)-1H-pyrazole-5-carboxylic acid
- HMS3356K22
- 5071-61-4
- AC-26517
- CHEMBL397785
- MLS001065888
- 5-Phenyl-1H-pyrazole-3-carboxylic acid, AldrichCPR
- 5-Phenylpyrazole-3-carboxylic acid
- AS-82144
- SY004192
- Q27164500
- PS-3041
- AB00463493-03
- BDBM50241312
- Z104442688
- J-002966
- NCGC00342274-01
- AMY11889
- F52631
- AB01334874-02
- J-517915
- HMS1648H01
- SR-01000597145
- MFCD01248821
- EN300-14809
- STK560194
- DB-071246
- 3-phenyl-1H-pyrazol-2-ium-5-carboxylate
- STK387518
- ALBB-006580
- 5-phenyl-1h-pyrazole-3-carboxylic acid
-
- MDL: MFCD01248821
- Inchi: 1S/C10H8N2O2/c13-10(14)9-6-8(11-12-9)7-4-2-1-3-5-7/h1-6H,(H,11,12)(H,13,14)
- InChI Key: QBPUOAJBMXXBNU-UHFFFAOYSA-N
- SMILES: OC(C1=CC(C2C=CC=CC=2)=NN1)=O
- BRN: 0609874
Computed Properties
- Exact Mass: 188.05900
- Monoisotopic Mass: 188.058577502 g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 14
- Rotatable Bond Count: 2
- Complexity: 214
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 66
- Molecular Weight: 188.18
- Surface Charge: 0
- Tautomer Count: 4
- XLogP3: 1.7
Experimental Properties
- Color/Form: Not determined
- Density: 1.4±0.1 g/cm3
- Melting Point: 238-242?°C (dec.) (lit.)
- Boiling Point: 496.5±33.0 °C at 760 mmHg
- Flash Point: 254.1±25.4 °C
- Refractive Index: 1.645
- PSA: 65.98000
- LogP: 1.77490
- Solubility: Not determined
- Vapor Pressure: 0.0±1.3 mmHg at 25°C
5-phenyl-1h-pyrazole-3-carboxylic acid Security Information
-
Symbol:
- Signal Word:Warning
- Hazard Statement: H315-H319-H335
- Warning Statement: P261-P305+P351+P338
- Hazardous Material transportation number:NONH for all modes of transport
- WGK Germany:3
- Hazard Category Code: 36/37/38
- Safety Instruction: S26-S36
-
Hazardous Material Identification:
- Safety Term:S26-36
- Risk Phrases:R36/37/38
- HazardClass:IRRITANT
- Storage Condition:storage at -4℃ (1-2weeks), longer storage period at -20℃ (1-2years)
5-phenyl-1h-pyrazole-3-carboxylic acid Customs Data
- HS CODE:2933199090
- Customs Data:
China Customs Code:
2933199090Overview:
2933199090. Other structurally non fused pyrazole ring compounds. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date
Summary:
2933199090. other compounds containing an unfused pyrazole ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
5-phenyl-1h-pyrazole-3-carboxylic acid Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| XI GE MA AO DE LI QI ( SHANG HAI ) MAO YI Co., Ltd. | 633739-1G |
5-phenyl-1h-pyrazole-3-carboxylic acid |
1134-49-2 | 97% | 1G |
1582.11 | 2021-05-17 | |
| CHENG DOU FEI BO YI YAO Technology Co., Ltd. | FB01546-50g |
5-phenyl-1h-pyrazole-3-carboxylic Acid |
1134-49-2 | 95% | 50g |
$500 | 2023-09-07 | |
| TRC | P266606-100mg |
5-phenyl-1h-pyrazole-3-carboxylic acid |
1134-49-2 | 100mg |
$ 50.00 | 2022-06-03 | ||
| TRC | P266606-500mg |
5-phenyl-1h-pyrazole-3-carboxylic acid |
1134-49-2 | 500mg |
$ 65.00 | 2022-06-03 | ||
| TRC | P266606-1g |
5-phenyl-1h-pyrazole-3-carboxylic acid |
1134-49-2 | 1g |
$ 80.00 | 2022-06-03 | ||
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | P69740-5g |
3-Phenyl-1H-pyrazole-5-carboxylic acid |
1134-49-2 | 95% | 5g |
¥573.0 | 2024-07-19 | |
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | P69740-1g |
3-Phenyl-1H-pyrazole-5-carboxylic acid |
1134-49-2 | 95% | 1g |
¥175.0 | 2024-07-19 | |
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | P69740-100mg |
3-Phenyl-1H-pyrazole-5-carboxylic acid |
1134-49-2 | 100mg |
¥66.0 | 2021-09-04 | ||
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | P69740-250mg |
3-Phenyl-1H-pyrazole-5-carboxylic acid |
1134-49-2 | 250mg |
¥76.0 | 2021-09-04 | ||
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | L-LF313-1g |
5-phenyl-1h-pyrazole-3-carboxylic acid |
1134-49-2 | 97% | 1g |
¥219.0 | 2022-02-28 |
5-phenyl-1h-pyrazole-3-carboxylic acid Suppliers
5-phenyl-1h-pyrazole-3-carboxylic acid Related Literature
-
Marcos A. P. Martins,Geórgia C. Zimmer,Leticia V. Rodrigues,Tainára Orlando,Lilian Buriol,Mateo Alajarin,Jose Berna,Clarissa P. Frizzo,Helio G. Bonacorso,Nilo Zanatta New J. Chem. 2017 41 13303
-
Tobias Persson,Christina W. Yde,Jakob E. Rasmussen,Tine L. Rasmussen,Barbara Guerra,Olaf-Georg Issinger,John Nielsen Org. Biomol. Chem. 2007 5 3963
-
3. Cycloaddition of nitrile imines to resin-bound enamines: a solid phase synthesis of 1,4-diarylpyrazolesAndrew C. Donohue,Sue Pallich,Tom D. McCarthy imines to resin-bound enamines: a solid phase synthesis of 14-diarylpyrazoles. Andrew C. Donohue Sue Pallich Tom D. McCarthy J. Chem. Soc. Perkin Trans. 1 2001 2817
-
Yunnan Gong,Chongbo Liu,Huiliang Wen,Liushui Yan,Zhiqiang Xiong,Liang Ding New J. Chem. 2011 35 865
Additional information on 5-phenyl-1h-pyrazole-3-carboxylic acid
Introduction to 5-phenyl-1H-pyrazole-3-carboxylic acid (CAS No. 1134-49-2)
5-phenyl-1H-pyrazole-3-carboxylic acid, with the chemical formula C?H?N?O?, is a significant compound in the field of pharmaceutical chemistry and organic synthesis. This heterocyclic aromatic carboxylic acid derivative has garnered considerable attention due to its versatile applications and structural properties. The presence of both a phenyl group and a pyrazole ring imparts unique reactivity and biological potential, making it a valuable scaffold for drug discovery and material science research.
The compound is formally identified by its CAS number, 1134-49-2, which distinguishes it from other isomers and analogs in chemical databases. This numbering system ensures precise identification and facilitates standardized communication among researchers and industry professionals. The molecular structure of 5-phenyl-1H-pyrazole-3-carboxylic acid features a pyrazole core substituted with a phenyl group at the 5-position and a carboxylic acid functional group at the 3-position. This arrangement contributes to its stability and reactivity, enabling diverse synthetic pathways and functionalization strategies.
In recent years, 5-phenyl-1H-pyrazole-3-carboxylic acid has been extensively studied for its pharmacological properties. Pyrazole derivatives are well-known for their broad spectrum of biological activities, including anti-inflammatory, antimicrobial, antiviral, and anticancer effects. The introduction of a phenyl moiety further enhances these properties by modulating electronic and steric interactions with biological targets. Current research highlights its potential in developing novel therapeutic agents targeting chronic diseases and inflammatory conditions.
One of the most compelling aspects of 5-phenyl-1H-pyrazole-3-carboxylic acid is its role as a key intermediate in the synthesis of more complex molecules. Its carboxylic acid group allows for further derivatization via esterification, amidation, or coupling reactions, enabling the creation of diverse pharmacophores. Similarly, the pyrazole ring can be modified through alkylation, acylation, or halogenation to tailor specific biological activities. These synthetic flexibility makes it an indispensable tool in medicinal chemistry laboratories.
Recent advancements in computational chemistry have also shed light on the structural properties of 5-phenyl-1H-pyrazole-3-carboxylic acid. Molecular modeling studies indicate that the compound exhibits favorable binding affinities with various enzymes and receptors, suggesting its potential as a lead compound in drug development. Additionally, spectroscopic techniques such as NMR and mass spectrometry have been employed to elucidate its molecular structure and dynamics, providing insights into its behavior in different environments.
The pharmaceutical industry has taken notice of 5-phenyl-1H-pyrazole-3-carboxylic acid due to its promising therapeutic profile. Several clinical trials are currently underway to evaluate its efficacy in treating conditions such as rheumatoid arthritis, psoriasis, and certain types of cancer. Preliminary results suggest that derivatives of this compound exhibit significant anti-inflammatory and immunomodulatory effects, making them attractive candidates for further development.
Beyond pharmaceutical applications, 5-phenyl-1H-pyrazole-3-carboxylic acid finds utility in material science research. Its unique electronic properties make it suitable for use in organic electronics, including light-emitting diodes (LEDs) and photovoltaic cells. Researchers have explored its potential as a building block for conjugated polymers and small-molecule semiconductors, contributing to advancements in sustainable energy technologies.
The synthesis of 5-phenyl-1H-pyrazole-3-carboxylic acid can be achieved through multiple pathways, each offering distinct advantages depending on scalability and purity requirements. Common methods include condensation reactions between phenylacetic acid derivatives with hydrazine hydrate followed by oxidation or carboxylation steps. Advances in green chemistry have also led to the development of more environmentally friendly synthetic routes, minimizing waste generation and reducing energy consumption.
In conclusion,5-phenyl-1H-pyrazole-3-carboxylic acid (CAS No. 1134-49-2) is a multifaceted compound with significant implications in pharmaceuticals and materials science. Its structural features enable diverse functionalization strategies, while its biological activities make it a promising candidate for drug development. Ongoing research continues to uncover new applications for this versatile molecule, solidifying its importance in modern chemistry.
1134-49-2 (5-phenyl-1h-pyrazole-3-carboxylic acid) Related Products
- 46413-67-6(3-(4-methylphenyl)-1H-pyrazole-5-carboxylic acid)
- 164295-94-7(3-(2-naphthyl)-1{H}-pyrazole-5-carboxylic acid)
- 1197631-29-0(3-(3,4-dimethylphenyl)-1H-pyrazole-5-carboxylic acid)
- 1037816-85-5(3-biphenyl-4-yl-1{H}-pyrazole-5-carboxylic acid)
- 890591-84-1(3-(4-Ethylphenyl)-1H-pyrazole-5-carboxylic acid)
- 890621-41-7(1H-Pyrazole-5-carboxylicacid, 3-(2-methylphenyl)-)
- 890007-12-2(3-(4-methylphenyl)-1H-pyrazole-5-carboxylic Acid)
- 690631-98-2(5-(3-hydroxyphenyl)-1H-pyrazole-3-carboxylic acid)
- 870704-22-6(3-(4-fluorophenyl)-1H-pyrazole-5-carboxylic acid)
- 5071-61-4(3-Phenyl-1H-pyrazole-5-carboxylic acid)